Dr. Numthip Chitravas, MD

Dr. Chitravas practices at Piedmont Cartersville Medical Center in Cartersville, Georgia, part of Piedmont Healthcare.

Dr. Chitravas' NPI, 1073761789, was assigned on September 5, 2008. Dr. Chitravas holds New York license 318516.

Dr. Chitravas' primary practice is Piedmont Cartersville Medical Center, at 960 Joe Frank Harris Parkway, Cartersville, GA 30120 in Bartow County. The practice phone is (470) 490-1000.

Dr. Chitravas' primary practice is Piedmont Cartersville Medical Center in Cartersville, Georgia, part of Piedmont Healthcare. Dr. Chitravas is also affiliated with NCH Baker Hospital. The medical group on file is Piedmont Hospitalist Physicians Group. Dmand AI also links Dr. Chitravas to 5 more hospitals, 21 medical groups and 11 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chitravas practices, 18 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chitravas' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chitravas is board certified in neuromuscular medicine by the American Board of Physical Medicine and Rehabilitation. Dmand AI has Dr. Chitravas' licenses on file in 4 states: New York, Maryland, Texas and Washington.

CMS data shows 395 Medicare services from Dr. Chitravas across 4 procedure codes in 2024, for 405 Medicare patients. Medicare paid $17,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 405 Medicare patients who saw Dr. Chitravas in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chitravas' median patient age at 69, with 52% women.

In 2023, Dr. Chitravas wrote 20 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $2,014 in total drug cost. In 2022, CMS named 98 claims across 6 drugs.

Dr. Chitravas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chitravas as offering telehealth.

Dmand AI links 1 paper to Dr. Chitravas in 2011.

CMS Open Payments shows 209 general payments to Dr. Chitravas from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. LivaNova USA, Inc. paid the most, $849.